Mercy Health Hospital Earns Joint Commission Certification and Gold Seal of Approval for Blood and Marrow Transplant Program

(CINCINNATI; February 18, 2015) - Mercy Health - Cincinnati, which provides advanced, compassionate, quality care in your neighborhood through its care network, announces that The Jewish Hospital – Mercy Health has earned the Joint Commission’s Gold Seal of Approval® for its blood and marrow transplant program, a key offering of the hospital’s Blood Cancer Center.

“Every day, I see how the dedication and expertise of the Blood Cancer Center team changes the lives of our patients and their families following what for many is a devastating diagnosis. This certification validates the high quality care the team provides our blood and marrow transplant patients,” said Pat Davis-Hagens, CEO of The Jewish Hospital. “They work at the highest level of our profession and do what’s best for our patients.”

“Our focus is on treating the patient, not solely the cancer,” said James H. Essell, MD, Medical Director the Blood Cancer Center.

The Jewish Hospital Blood Cancer Center earned the Gold Seal of Approval®, a certification award that recognizes The Jewish Hospital’s dedication to continuous compliance with The Joint Commission’s state-of-the-art standards. The Jewish Hospital underwent a rigorous on-site review, during which a Joint Commission expert evaluated it for compliance with standards of care specific to the needs of blood and marrow transplant patients and families, including infection prevention and control, leadership and medication management, before earning the Gold Seal.

"In achieving Joint Commission certification, The Jewish Hospital - Mercy Health has demonstrated its commitment to the highest level of care for its patients undergoing blood and marrow transplants," says Jean Range, M.S., R.N., C.P.H.Q. executive director, Disease-Specific Care Certification, The Joint Commission. “Certification is a voluntary process and I commend The Jewish Hospital for successfully undertaking this challenge to elevate its standard of care and instill confidence in the community it serves.”

The Joint Commission’s Disease-Specific Care Certification Program, launched in 2002, is designed to evaluate clinical programs across the continuum of care. Certification requirements address three core areas:
• compliance with consensus-based national standards
• effective use of evidence-based clinical practice guidelines to manage and optimize care
• an organized approach to performance measurement and improvement activities

Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission evaluates and accredits more than 20,000 health care organizations and programs in the United States, including more than 10,600 hospitals and home care organizations, and more than 6,600 other health care organizations that provide long term care, behavioral health care, laboratory and ambulatory care services. The Joint Commission also certifies more than 2,400 disease-specific care programs such as stroke, heart failure, joint replacement and stroke rehabilitation, and 400 health care staffing services. An independent, not-for-profit organization, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. Learn more about The Joint Commission at www.jointcommission.org.

In addition to this new certification, the Blood Cancer Center has maintained accreditation by the Foundation for Cellular Therapy since 2006. Only 194 centers in the world that have achieved these rigorous quality standards, reflecting the Center’s commitment to providing quality patient care related to cellular therapy. The Blood Cancer Center is a collections and transplant center for the National Marrow Donor Program. It is a member of the Eastern Cooperative Oncology Group, the Blood and Marrow Transplant Clinical Trials Network and the Interlink Health Services Transplant Network and is a Blue Distinction Center for Transplants. In addition, through Mercy Health’s partnership with OHC/Oncology Hematology Care, the Blood Cancer Center connects patients with OHC’s strategic partner, the Sarah Cannon Research Institute. For more information, please call 513-686-5482.

The Blood Cancer Center at The Jewish Hospital is the only center in Cincinnati that can provide the full range of care for adults with blood diseases, including blood and marrow transplants. In 2014, the team performed 110 transplants and it has completed more than 1,700 transplants since the Center opened in 1993. The team at the Blood Cancer Center annually treats more than 120 new patients with acute leukemia and high grade lymphoma and participates in a wide range of research studies, including cord blood transplants. Last year, it enrolled more than 45 patients in clinical trials. Physicians in the Center will see any patient referred to them within three to five business days and will see patients with high-grade lymphoma or leukemia on the same day as referral. All Blood Cancer Center physicians are board certified in hematology and/or oncology.